Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Gastroenterology
|
July 17, 2020
An Extraordinary Cause of Dyspnea and Weight Loss
Timothy P Hanrahan, Mark Goodwin, Adam Testro
Critical Care (London, England)
|
August 11, 2016
Antibiotic dosing in obesity: a BIG challenge
Timothy P Hanrahan, Jeffrey Lipman, Jason A Roberts
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 27, 2020
Lessons From COVID-19, ACE2, and Intestinal Inflammation: Could a Virus Trigger Chronic Intestinal Inflammation?
Timothy P Hanrahan, John S Lubel, Mayur Garg
Alimentary Pharmacology & Therapeutics
|
January 24, 2023
Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis
Sarah-Louise Gillespie, Timothy P Hanrahan, Don C Rockey, et al.
Critical Care Medicine
|
April 16, 2015
The authors reply
Timothy P Hanrahan, Georgina Harlow, Joel M Dulhunty, et al.
World Journal of Transplantation
|
August 18, 2022
Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients
Penelope Hey, Rudolf Hoermann, Paul Gow, et al.
Critical Care Medicine
|
August 2, 2014
Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*
Timothy P Hanrahan, Georgina Harlow, James Hutchinson, et al.
Diabetes Care
|
January 5, 2022
Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126
Peter S Hamblin, Rosemary Wong, Elif I Ekinci, et al.
Clinical Endocrinology
|
October 26, 2021
Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use
Peter S Hamblin, Rosemary Wong, Elif I Ekinci, et al.
Diabetes Care
|
April 26, 2021
Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes
Peter S Hamblin, Rosemary Wong, Elif I Ekinci, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Gastroenterology
|
July 17, 2020
An Extraordinary Cause of Dyspnea and Weight Loss
Timothy P Hanrahan, Mark Goodwin, Adam Testro
Critical Care (London, England)
|
August 11, 2016
Antibiotic dosing in obesity: a BIG challenge
Timothy P Hanrahan, Jeffrey Lipman, Jason A Roberts
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 27, 2020
Lessons From COVID-19, ACE2, and Intestinal Inflammation: Could a Virus Trigger Chronic Intestinal Inflammation?
Timothy P Hanrahan, John S Lubel, Mayur Garg
Alimentary Pharmacology & Therapeutics
|
January 24, 2023
Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis
Sarah-Louise Gillespie, Timothy P Hanrahan, Don C Rockey, et al.
Critical Care Medicine
|
April 16, 2015
The authors reply
Timothy P Hanrahan, Georgina Harlow, Joel M Dulhunty, et al.
World Journal of Transplantation
|
August 18, 2022
Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients
Penelope Hey, Rudolf Hoermann, Paul Gow, et al.
Critical Care Medicine
|
August 2, 2014
Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*
Timothy P Hanrahan, Georgina Harlow, James Hutchinson, et al.
Diabetes Care
|
January 5, 2022
Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126
Peter S Hamblin, Rosemary Wong, Elif I Ekinci, et al.
Clinical Endocrinology
|
October 26, 2021
Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use
Peter S Hamblin, Rosemary Wong, Elif I Ekinci, et al.
Diabetes Care
|
April 26, 2021
Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes
Peter S Hamblin, Rosemary Wong, Elif I Ekinci, et al.
Page
of 2